All News
Judge Rules Some NIH Grant Cuts Were Illegal and Says Funding Must Be Restored
(MedPage Today) -- A federal judge ruled Monday it was illegal for the Trump administration to cancel several hundred research grants, adding that the cuts raise serious questions about racial discri
Read MoreTargeted Combo Yields PFS of 40 Months in HER2-Positive Breast Cancer
(MedPage Today) -- At the recent American Society of Clinical Oncology (ASCO) meeting, the DESTINY-Breast09 trial drew attention for its impressive first-line results in HER2-positive locally advance
Read MoreMedicare Rules Finally Ease Access to Simpler Home Ventilation Devices for COPD
(MedPage Today) -- Newly released Medicare national coverage determinations are set to reshape the home ventilation landscape for chronic obstructive pulmonary disease (COPD).
Read MoreMatthew Perry's Doctor Pleads Guilty; CDC Official Resigns; $7.4B Opioid Settlement
(MedPage Today) -- Note that some links may require registration or subscription.
Read MoreSTAT+: Lilly adds highest Zepbound doses to DTC offering
Plus more biotech news brought to you by The Readout.
Read MoreSTAT+: Doctors lose Medicare pay bump in Senate version of tax bill
The Medicare pay bump for doctors that was part of the House version of Republicans’ tax bill was dropped in the Senate’s version, released Monday evening.
Read MoreFired ACIP members are ‘deeply concerned’ about the future
Plus more health news stories to read today.
Read MoreSTAT+: Pharmalittle: We’re reading about a Lilly deal, a gene therapy shock for Duchenne families, and more
In today's Pharmalittle roundup, we're reading about a Lilly deal, a gene therapy shock for Duchenne families, and more.
Read MoreWaska: the cost of spiritual healing in the Amazon
The plant medicine hayakwaska (ayahuasca), marketed as a mystical shortcut to healing and enlightenment, is an example of what the Indigenous storyteller Nina Gualinga, sees as commodification and ext
Read MoreSTAT+: Eli Lilly to buy gene-editing biotech Verve for up to $1.3 billion
Eli Lilly said Tuesday that it will acquire Verve Therapeutics, a biotech developing gene-editing therapies for cardiovascular disease.
Read More